Degertekin, B. Et Al. 2020. Real-world efficacy and safety of Ledipasvir plus Sofosbuvir and Ombitasvir/Paritaprevir/Ritonavir +/- Dasabuvir combination therapies for chronic hepatitis C: A Turkish experience. TURKISH JOURNAL OF GASTROENTEROLOGY , vol.31, no.12 , 883-893.

Degertekin, B., DEMİR, M., AKARCA, U. S., Kani, H. T., ÜÇBİLEK, E., Yildirim, E., ... Guzelbulut, F.(2020). Real-world efficacy and safety of Ledipasvir plus Sofosbuvir and Ombitasvir/Paritaprevir/Ritonavir +/- Dasabuvir combination therapies for chronic hepatitis C: A Turkish experience. TURKISH JOURNAL OF GASTROENTEROLOGY , vol.31, no.12, 883-893.

Degertekin, Bulent Et Al. "Real-world efficacy and safety of Ledipasvir plus Sofosbuvir and Ombitasvir/Paritaprevir/Ritonavir +/- Dasabuvir combination therapies for chronic hepatitis C: A Turkish experience," TURKISH JOURNAL OF GASTROENTEROLOGY , vol.31, no.12, 883-893, 2020

Degertekin, Bulent Et Al. "Real-world efficacy and safety of Ledipasvir plus Sofosbuvir and Ombitasvir/Paritaprevir/Ritonavir +/- Dasabuvir combination therapies for chronic hepatitis C: A Turkish experience." TURKISH JOURNAL OF GASTROENTEROLOGY , vol.31, no.12, pp.883-893, 2020

Degertekin, B. Et Al. (2020) . "Real-world efficacy and safety of Ledipasvir plus Sofosbuvir and Ombitasvir/Paritaprevir/Ritonavir +/- Dasabuvir combination therapies for chronic hepatitis C: A Turkish experience." TURKISH JOURNAL OF GASTROENTEROLOGY , vol.31, no.12, pp.883-893.

@article{article, author={Bulent Degertekin Et Al. }, title={Real-world efficacy and safety of Ledipasvir plus Sofosbuvir and Ombitasvir/Paritaprevir/Ritonavir +/- Dasabuvir combination therapies for chronic hepatitis C: A Turkish experience}, journal={TURKISH JOURNAL OF GASTROENTEROLOGY}, year=2020, pages={883-893} }